Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joan How

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Therapeutic Advances in Hematology|March 2, 2017
Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of diseaseJoan How, Amy Zhou, Stephen T Oh
Connecticut Medicine|May 12, 2015
Are Nectarines to Blame? A Case Report and Literature Review of Spontaneous Bacterial Peritonitis Due to Listeria monocytogenesJoan How, Marwan M Azar, Jaimie P Meyer
British Journal of Haematology|October 20, 2017
Distinct clinical, laboratory and molecular features of myeloproliferative neoplasm patients with splanchnic vein thrombosisJoan How, Kathryn M Trinkaus, Stephen T Oh
Clinical Lung Cancer|March 2, 2017
Pulsatile Erlotinib in EGFR-Positive Non-Small-Cell Lung Cancer Patients With Leptomeningeal and Brain Metastases: Review of the LiteratureJoan How, Janelle Mann, Andrew N Laczniak, et al.
Histochemistry and Cell Biology|January 17, 2014
Macrophage expression of tartrate-resistant acid phosphatase as a prognostic indicator in colon cancerJoan How, Jason R Brown, Sasha Saylor, et al.
Atherosclerosis|December 19, 2024
Readmission outcomes after acute coronary syndrome among patients with myeloproliferative neoplasmsOrly Leiva, Sophia Zhou, Joan How, et al.
Journal of Thrombosis and Thrombolysis|October 15, 2023
In-Hospital and readmission outcomes of patients with myeloproliferative neoplasms and atrial fibrillation: insights from the National Readmissions DatabaseOrly Leiva, Joan How, Jeremy Grevet, et al.
Leukemia|January 13, 2019
Young versus old age at diagnosis confers distinct genomic profiles in patients with polycythemia veraJared S Fowles, Joan How, Maggie J Allen, et al.
International Journal of Cardiology. Heart & Vasculature|January 4, 2024
In-Hospital and readmission outcomes of patients with myeloproliferative neoplasms and heart failure: Insights from the National Readmissions DatabaseOrly Leiva, Jose Alvarez-Cardona, Joan How, et al.
The Neurologist|November 2, 2016
Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the LiteratureJoan How, Margaret Blattner, Susan Fowler, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Therapeutic Advances in Hematology|March 2, 2017
Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of diseaseJoan How, Amy Zhou, Stephen T Oh
Connecticut Medicine|May 12, 2015
Are Nectarines to Blame? A Case Report and Literature Review of Spontaneous Bacterial Peritonitis Due to Listeria monocytogenesJoan How, Marwan M Azar, Jaimie P Meyer
British Journal of Haematology|October 20, 2017
Distinct clinical, laboratory and molecular features of myeloproliferative neoplasm patients with splanchnic vein thrombosisJoan How, Kathryn M Trinkaus, Stephen T Oh
Clinical Lung Cancer|March 2, 2017
Pulsatile Erlotinib in EGFR-Positive Non-Small-Cell Lung Cancer Patients With Leptomeningeal and Brain Metastases: Review of the LiteratureJoan How, Janelle Mann, Andrew N Laczniak, et al.
Histochemistry and Cell Biology|January 17, 2014
Macrophage expression of tartrate-resistant acid phosphatase as a prognostic indicator in colon cancerJoan How, Jason R Brown, Sasha Saylor, et al.
Atherosclerosis|December 19, 2024
Readmission outcomes after acute coronary syndrome among patients with myeloproliferative neoplasmsOrly Leiva, Sophia Zhou, Joan How, et al.
Journal of Thrombosis and Thrombolysis|October 15, 2023
In-Hospital and readmission outcomes of patients with myeloproliferative neoplasms and atrial fibrillation: insights from the National Readmissions DatabaseOrly Leiva, Joan How, Jeremy Grevet, et al.
Leukemia|January 13, 2019
Young versus old age at diagnosis confers distinct genomic profiles in patients with polycythemia veraJared S Fowles, Joan How, Maggie J Allen, et al.
International Journal of Cardiology. Heart & Vasculature|January 4, 2024
In-Hospital and readmission outcomes of patients with myeloproliferative neoplasms and heart failure: Insights from the National Readmissions DatabaseOrly Leiva, Jose Alvarez-Cardona, Joan How, et al.
The Neurologist|November 2, 2016
Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the LiteratureJoan How, Margaret Blattner, Susan Fowler, et al.
Pageof 5